Details

Autor(en) / Beteiligte

• Zhang, Hongli
• Feng, Qingqing
• Chen, Wei-Dong
• Wang, Yan-Dong

Titel

HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers

Ist Teil von

• International journal of molecular sciences, 2018-10, Vol.19 (11), p.3295

Ort / Verlag

Switzerland: MDPI AG

Erscheinungsjahr

2018

Quelle

MEDLINE

Beschreibungen/Notizen

• The HGF/c-MET pathway is active in the development of digestive system cancers, indicating that inhibition of HGF/c-MET signaling may have therapeutic potential. Various HGF/c-MET signaling inhibitors, mainly c-MET inhibitors, have been tested in clinical trials. The observed efficacy and adverse events of some c-MET inhibitors were not very suitable for treating digestive system cancers. The development of new HGF/c-MET inhibitors in preclinical studies may bring promising treatments and synergistic combination (traditional anticancer drugs and c-MET inhibitors) strategies provided anacceptable safety and tolerability. Insights into miRNA biology and miRNA therapeutics have made miRNAs attractive tools to inhibit HGF/c-MET signaling. Recent reports show that several microRNAs participate in inhibiting HGF/c-MET signaling networks through antagonizing c-MET or HGF in digestive system cancers, and the miRNAs-HGF/c-MET axis plays crucial and novel roles for cancer treatment. In the current review, we will discuss recent findings about inhibitors of HGF/c-MET signaling in treating digestive system cancers, and how miRNAs regulate digestive system cancers via mediating HGF/c-MET pathway.